Flow State Investments’s Amedisys AMED Stock Holding History

Flow State Investments’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-17,000	Closed	-$1.64M	–	3
2024 Q3	$1.64M	Sell	17,000 -76,129	-82%	-$7.43M	0.67%	31
2024 Q2	$8.55M	Buy	93,129 +10,129	+12%	+$940K	2.7%	10
2024 Q1	$7.65M	Sell	83,000 -3,000	-3%	-$281K	2.18%	11
2023 Q4	$8.18M	Buy	86,000 +78,000	+975%	+$7.29M	2.57%	8
2023 Q3	$747K	Buy	+8,000	New	+$739K	0.23%	76

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Flow State Investments's AMED Position: Q4 2024 in Review

Flow State Investments sold out of Amedisys (AMED) in Q4 2024, closing a stake of 17,000 shares — an estimated $1.64M sold.

Flow State Investments first reported a position in AMED in Q3 2023 and held it in 5 quarters. The position peaked at $8.55M in Q2 2024. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

Flow State Investments reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
Flow State Investments sold 17,000 Amedisys shares in Q4 2024, an estimated $1.64M.
Flow State Investments first reported a position in Amedisys in Q3 2023 and held it in 5 quarters.
Flow State Investments's Amedisys position peaked at $8.55M in Q2 2024.
290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Flow State Investments's 13F filing for Q4 2024.